[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363185-105":59,"doc-detail-363185-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ataxia-telangiectasia-mutated-atm-kinase-as-a-predictive-biomarker-in-clinical-oncology-implications-for-a-precision-treatment-approach","Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology - implications for a precision treatment approach","","ATM (ataxia telangiectasia mutated) kinase is a central mediator of the DNA damage response, maintaining genomic integrity after genotoxic insults. Germline and somatic alterations in ATM are common in tumors, and pathogenic variants affect an estimated 1 in 100 individuals worldwide. Evidence supports ATM as a biomarker for therapeutic sensitivity: ATM-deficient tumors show increased sensitivity to radiotherapy and chemotherapy and enable synthetic lethality strategies. The review summarizes ATM structure, function, and partners, addresses key gaps for drug-combination rationales, and reviews preclinical and clinical studies positioning ATM in precision oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ataxia-telangiectasia-mutated-atm-kinase-as-a-predictive-biomarker-in-clinical-oncology-implications-for-a-precision-treatment-approach/363185/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ataxia-telangiectasia-mutated-atm-kinase-as-a-predictive-biomarker-in-clinical-oncology-implications-for-a-precision-treatment-approach/363185.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does ATM kinase play in cancer biology?","Question",{"text":112,"@type":113},"ATM kinase is a core mediator of the DNA damage response, recognizing and helping repair DNA damage by activating downstream checkpoint and repair pathways. Loss or mutation of ATM is linked to genomic instability and a distinct phenotype with increased hypermutation and immunogenicity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does ATM deficiency influence treatment response?",{"text":117,"@type":113},"ATM-deficient tumors tend to be more sensitive to radiotherapy and chemotherapy. The review also highlights opportunities for synthetic lethality approaches, including sensitization to ATR and PARP inhibitors.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review cover about ATM as a biomarker?",{"text":121,"@type":113},"It summarizes ATM kinase structure and function, interacting partners, and the evidence supporting ATM utility as a predictive biomarker. It further discusses critical knowledge gaps and evaluates preclinical and clinical studies relevant to precision oncology.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363185,1790449679,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Neoplasia 77 (2026) 101309  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Review Article\u003Cbr>Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach |  |  | |\n| --- | --- | --- | --- |\n| Ann T. Phama,b , Fenghua Yuan a,b, Nagaraj S. Nagathihallia,c, Austin R. Doscha,b,* \u003Cbr>a Division of Colon & Rectal Surgery, Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida b Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida\u003Cbr>c Division of Surgical Oncology, Department of Surgery, University of Miami Miller School of Medicine, Miami, Florida |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>ATM\u003Cbr>Ataxia telangiectasia mutated kinase DNA\u003Cbr>Damage repair\u003Cbr>Homologous recombination\u003Cbr>Cancer\u003Cbr>ATR inhibition |  | ATM (ataxia telangiectasia mutated) kinase is a central mediator of the DNA damage response (DDR), with established roles in maintaining genomic integrity in response to genotoxic insults. Both germline and somatic alterations in ATM occur frequently in tumors, with pathogenic variants affecting an estimated 1 in 100 individuals worldwide. Emerging evidence has shown its utility as a biomarker for therapeutic sensitivity. ATMdeficient tumors exhibit increased sensitivity to radiotherapy, chemotherapy and present opportunities for synthetic lethality approaches. Notably, ATM loss sensitizes tumors to ATR and PARP inhibitors. This review summarizes the structure and function of ATM kinase and its interacting partners, while addressing critical knowledge gaps in recently described rationale for drug combinations that induce selective synthetic lethality in tumors cells. We examine how these approaches can be leveraged to improve standard chemotherapeutic and immunotherapeutic treatments in cancer. Additionally, we highlight the key preclinical and clinical studies evaluating ATM as a predictive biomarker and discuss its evolving role in precision oncology. |  |\n\nIntroduction  \nATM is a serine/threonine kinase encoded by the ATM gene located on chromosome 11q22-23. ATM kinase plays a key role in recognizing and repairing DNA damage through activation of downstream DNA replication checkpoint and repair pathways[1]. Thus, the loss or mutation ofATM is inherently associated with genomic instability, inducing a unique phenotype characterized by hypermutation and enhanced immunogenicity[2–5]. Recent studies have highlighted ATM loss as a key vulnerability in several tumor types, yet much is still unknown about the heterogenous landscape of ATM alterations in dictating tumor biology and treatment response. In this review, we summarize the  \nmolecular role of ATM in DNA damage repair, summarize its utility as a predictive biomarker of response to chemotherapy, targeted inhibitors, and immunotherapy, and explore opportunities, challenges, and critical knowledge gaps in the clinical management of ATM-deficient tumors.  \nThe structure of ATM kinase  \nThe ATM gene comprises 66 exons, encoding a large 350 kDa serine/ threonine kinase protein of 3056 amino acids. ATM belongs to thephosphoinositide 3-kinase-related kinase (PIKK) family, sharing structural homology with members like mammalian target of rapamycin (mTOR), suppressor of mutagenesis in genitalia 1 (SMG1), and the  \nAbbreviations: ATM, ataxia telangiectasia mutated; DDR, DNA damage response; ATR, ataxia telangiectasia and Rad3-related; mTOR, mammalian target of rapamycin; SMG1, suppressor of mutagenesis in genitalia 1; DNA-PKcs, DNA-dependent protein kinase catalytic subunit; ATMIN, ATM interacting protein; NBS1, Nibrin; MRN complex, MRE11–RAD50–NBS1 complex; NKX3.1, NK3 homeobox 1; FAT domain, FRAP–ATM–TRRAP domain; PI3K, phosphatidylinositol 3-kinase; PRD, PIKK regulatory domain","cbCaic8YTTrCimBj","https://ap.wps.com/l/cbCaic8YTTrCimBj","pdf",1919713,14,"English","# Contents lists\n## Review Article\n## Article title\n## Authors\n## Abstract\n## Introduction\n## The structure of ATM kinase\n## Abbreviations","[{\"question\":\"What role does ATM kinase play in cancer biology?\",\"answer\":\"ATM kinase is a core mediator of the DNA damage response, recognizing and helping repair DNA damage by activating downstream checkpoint and repair pathways. Loss or mutation of ATM is linked to genomic instability and a distinct phenotype with increased hypermutation and immunogenicity.\"},{\"question\":\"How does ATM deficiency influence treatment response?\",\"answer\":\"ATM-deficient tumors tend to be more sensitive to radiotherapy and chemotherapy. The review also highlights opportunities for synthetic lethality approaches, including sensitization to ATR and PARP inhibitors.\"},{\"question\":\"What does the review cover about ATM as a biomarker?\",\"answer\":\"It summarizes ATM kinase structure and function, interacting partners, and the evidence supporting ATM utility as a predictive biomarker. It further discusses critical knowledge gaps and evaluates preclinical and clinical studies relevant to precision oncology.\"}]","Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology - implications for a precision treatment approach | PDF",1790150290,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/512179f450b0bf3fc165d220294ce16a.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28f5efc069e67766e89356aadda80baa.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2dbef6e8761bc4bd29b93eff1b374afd.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0e7e9a18a8f89d70ca0c055f5b69a1d.webp",980,1306]